(Q24293189)

GOA release 2020-03-11

Metallothionein 3

1 reference

supramolecular fiber organization

GOA release 2020-03-11

1 reference

Free Radical Biology and Medicine

GOA release 2020-03-11

1 reference

Gabriele Meloni

1

0 references

Milan Vašák

series ordinal

2

0 references

language of work or name

English

0 references

publication date

1 June 2011

0 references

published in

0 references

volume

50

0 references

issue

11

0 references

page(s)

1471-9

0 references

cites work

Alzheimer's disease related copper(II)- beta-amyloid peptide exhibits phenol monooxygenase and catechol oxidase activities

1 reference

https://api.crossref.org/works/10.1016%2FJ.FREERADBIOMED.2011.02.003

7 January 2021

Metal-catalyzed oxidation of alpha-synuclein in the presence of Copper(II) and hydrogen peroxide.

1 reference

https://api.crossref.org/works/10.1016%2FJ.FREERADBIOMED.2011.02.003

7 January 2021

Metallothionein-III antagonizes the neurotoxic and neurotrophic effects of amyloid beta peptides

1 reference

https://api.crossref.org/works/10.1016%2FJ.FREERADBIOMED.2011.02.003

7 January 2021

Oxidant types in copper-dioxygen chemistry: the ligand coordination defines the Cu(n)-O2 structure and subsequent reactivity

1 reference

https://api.crossref.org/works/10.1016%2FJ.FREERADBIOMED.2011.02.003

7 January 2021

Metal removal and substitution in vertebrate and invertebrate metallothioneins

1 reference

https://api.crossref.org/works/10.1016%2FJ.FREERADBIOMED.2011.02.003

7 January 2021

The growth inhibitory factor that is deficient in the Alzheimer's disease brain is a 68 amino acid metallothionein-like protein

1 reference

https://api.crossref.org/works/10.1016%2FJ.FREERADBIOMED.2011.02.003

7 January 2021

Solution structure and dynamics of human metallothionein-3 (MT-3).

1 reference

https://api.crossref.org/works/10.1016%2FJ.FREERADBIOMED.2011.02.003

7 January 2021

Formation of dopamine-mediated alpha-synuclein-soluble oligomers requires methionine oxidation

1 reference

https://api.crossref.org/works/10.1016%2FJ.FREERADBIOMED.2011.02.003

7 January 2021

Dopamine and the dopamine oxidation product 5,6-dihydroxylindole promote distinct on-pathway and off-pathway aggregation of alpha-synuclein in a pH-dependent manner

1 reference

https://api.crossref.org/works/10.1016%2FJ.FREERADBIOMED.2011.02.003

7 January 2021

A new method for purification of recombinant human alpha-synuclein in Escherichia coli.

1 reference

https://api.crossref.org/works/10.1016%2FJ.FREERADBIOMED.2011.02.003

7 January 2021

Ascorbate regulation and its neuroprotective role in the brain

1 reference

https://api.crossref.org/works/10.1016%2FJ.FREERADBIOMED.2011.02.003

7 January 2021

Metallothioneins: new functional and structural insights

1 reference

https://api.crossref.org/works/10.1016%2FJ.FREERADBIOMED.2011.02.003

7 January 2021

Safety, efficacy, and biomarker findings of PBT2 in targeting Abeta as a modifying therapy for Alzheimer's disease: a phase IIa, double-blind, randomised, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FJ.FREERADBIOMED.2011.02.003

7 January 2021

Formation of mammalian Cu8-metallothionein in vitro: evidence for the existence of two Cu(I)4-thiolate clusters

1 reference

https://api.crossref.org/works/10.1016%2FJ.FREERADBIOMED.2011.02.003

7 January 2021

Zinc(II), cadmium(II), and mercury(II) thiolate transitions in metallothionein

1 reference

https://api.crossref.org/works/10.1016%2FJ.FREERADBIOMED.2011.02.003

7 January 2021

Three-dimensional structure and dynamics of a brain specific growth inhibitory factor: metallothionein-3

1 reference

https://api.crossref.org/works/10.1016%2FJ.FREERADBIOMED.2011.02.003

7 January 2021

Redox reactions of the α-synuclein-Cu(2+) complex and their effects on neuronal cell viability

1 reference

https://api.crossref.org/works/10.1016%2FJ.FREERADBIOMED.2011.02.003

7 January 2021

The synucleins are a family of redox-active copper binding proteins

1 reference

https://api.crossref.org/works/10.1016%2FJ.FREERADBIOMED.2011.02.003

7 January 2021

Evidence for a dynamic structure of human neuronal growth inhibitory factor and for major rearrangements of its metal-thiolate clusters

1 reference

https://api.crossref.org/works/10.1016%2FJ.FREERADBIOMED.2011.02.003

7 January 2021

Copper homeostasis and neurodegenerative disorders (Alzheimer's, prion, and Parkinson's diseases and amyotrophic lateral sclerosis).

1 reference

https://api.crossref.org/works/10.1016%2FJ.FREERADBIOMED.2011.02.003

7 January 2021

Metal ion and metal chelate catalyzed oxidation of ascorbic acid by molecular oxygen. I. Cupric and ferric ion catalyzed oxidation

1 reference

https://api.crossref.org/works/10.1016%2FJ.FREERADBIOMED.2011.02.003

7 January 2021

Evidence for copper-dioxygen reactivity during alpha-synuclein fibril formation.

1 reference

https://api.crossref.org/works/10.1016%2FJ.FREERADBIOMED.2011.02.003

7 January 2021

Cu2+Binding Modes of Recombinant α-Synuclein − Insights from EPR Spectroscopy

1 reference

https://api.crossref.org/works/10.1016%2FJ.FREERADBIOMED.2011.02.003

7 January 2021

Site-specific interactions of Cu(II) with alpha and beta-synuclein: bridging the molecular gap between metal binding and aggregation

1 reference

https://api.crossref.org/works/10.1016%2FJ.FREERADBIOMED.2011.02.003

7 January 2021

Alpha-synuclein and neurodegenerative diseases

1 reference

https://api.crossref.org/works/10.1016%2FJ.FREERADBIOMED.2011.02.003

7 January 2021

Alpha-synuclein in Lewy bodies

1 reference

https://api.crossref.org/works/10.1016%2FJ.FREERADBIOMED.2011.02.003

7 January 2021

Metal swap between Zn7-metallothionein-3 and amyloid-beta-Cu protects against amyloid-beta toxicity.

1 reference

https://api.crossref.org/works/10.1016%2FJ.FREERADBIOMED.2011.02.003

7 January 2021

Neurodegenerative diseases and oxidative stress

1 reference

https://api.crossref.org/works/10.1016%2FJ.FREERADBIOMED.2011.02.003

7 January 2021

Iron, brain ageing and neurodegenerative disorders

1 reference

https://api.crossref.org/works/10.1016%2FJ.FREERADBIOMED.2011.02.003

7 January 2021

Copper(II)-induced self-oligomerization of alpha-synuclein.

1 reference

https://api.crossref.org/works/10.1016%2FJ.FREERADBIOMED.2011.02.003

7 January 2021

Copper neurotoxicity is dependent on dopamine-mediated copper uptake and one-electron reduction of aminochrome in a rat substantia nigra neuronal cell line

1 reference

https://api.crossref.org/works/10.1016%2FJ.FREERADBIOMED.2011.02.003

7 January 2021

Metal-triggered structural transformations, aggregation, and fibrillation of human alpha-synuclein. A possible molecular NK between Parkinson's disease and heavy metal exposure

1 reference

https://api.crossref.org/works/10.1016%2FJ.FREERADBIOMED.2011.02.003

7 January 2021

Growth inhibitory factor prevents neurite extension and the death of cortical neurons caused by high oxygen exposure through hydroxyl radical scavenging

1 reference

https://api.crossref.org/works/10.1016%2FJ.FREERADBIOMED.2011.02.003

7 January 2021

Metalloenzyme-like activity of Alzheimer's disease beta-amyloid. Cu-dependent catalytic conversion of dopamine, cholesterol, and biological reducing agents to neurotoxic H(2)O(2).

1 reference

https://api.crossref.org/works/10.1016%2FJ.FREERADBIOMED.2011.02.003

7 January 2021

Catechol oxidase-like oxidation chemistry of the 1-20 and 1-16 fragments of Alzheimer's disease-related beta-amyloid peptide: their structure-activity correlation and the fate of hydrogen peroxide

1 reference

https://api.crossref.org/works/10.1016%2FJ.FREERADBIOMED.2011.02.003

7 January 2021

Kinetic and structural analysis of the early oxidation products of dopamine: analysis of the interactions with alpha-synuclein.

1 reference

https://api.crossref.org/works/10.1016%2FJ.FREERADBIOMED.2011.02.003

7 January 2021

Redox silencing of copper in metal-linked neurodegenerative disorders: reaction of Zn7metallothionein-3 with Cu2+ ions.

1 reference

https://api.crossref.org/works/10.1016%2FJ.FREERADBIOMED.2011.02.003

7 January 2021

Does alpha-synuclein modulate dopaminergic synaptic content and tone at the synapse?

1 reference

https://api.crossref.org/works/10.1016%2FJ.FREERADBIOMED.2011.02.003

7 January 2021

Dopamine promotes alpha-synuclein aggregation into SDS-resistant soluble oligomers via a distinct folding pathway

1 reference

https://api.crossref.org/works/10.1016%2FJ.FREERADBIOMED.2011.02.003

7 January 2021

Unique copper-induced oligomers mediate alpha-synuclein toxicity

1 reference

https://api.crossref.org/works/10.1016%2FJ.FREERADBIOMED.2011.02.003

7 January 2021

Coumarin-3-carboxylic acid as a detector for hydroxyl radicals generated chemically and by gamma radiation

1 reference

https://api.crossref.org/works/10.1016%2FJ.FREERADBIOMED.2011.02.003

7 January 2021